This opportunity is currently closed.
Sign up for Content alerts to stay informed when this or related funding opportunities are posted.
Duchenne Muscular Dystrophy Research Program: Translational Research Award (worldwide)
The Duchenne Muscular Dystrophy Research Program: Translational Research Award from the Congressionally Directed Medical Research Programs (CDMRP) supports advanced translational research that will accelerate the movement of promising ideas in DMD research into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. This mechanism is intended to support established projects that have moved beyond the realm of basic research and proof of concept studies and have the potential to result in a near-term impact in clinical research or the clinic. Research projects investigating therapies that will be efficacious across the lifespan, including infants, toddlers, and non-ambulatory individuals,
are strongly encouraged. The program is open to researchers in the USA and worldwide. Applicants may apply for up to 1.25 million USD for up to 3 years. Indirect costs may be covered.
Funding Opportunity Number: HT9425-23-DMDRP-TRA
Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), August 2, 2023. Application Submission Deadline: 11:59 p.m. ET, August 23, 2023.
August 23, 2023